• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

9
3
3
3
1

COUNTRY

3
1

CATEGORIES

  • 6
  • 4
  • 2
  • 1
  • 1
  • 1

PRICE

10
10
11
15

PUBLISHED

1
1
5
15

PRODUCT TYPE

7
4
3
1

Search "Jazz Pharmaceuticals, Inc.-Deals & Alliances Report" returned 15 results.

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM

Gene Therapy Partnering Terms and Agreements (3rd Edition)

The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends...

December 2014
FROM

Cortex Pharmaceuticals, Inc. (CORX) - Financial and Strategic SWOT Analysis Review

Cortex Pharmaceuticals, Inc. (CORX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

September 2013
FROM
Orphan Drugs - Global Strategic Business Report Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Orphan Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts...

April 2015
FROM

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review

Vivus, Inc. (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher...

May 2015
FROM

Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - H2 2011

Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International, Inc. - Product Pipeline...

November 2011
FROM

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review

Par Pharmaceutical Companies, Inc. (PRX) - Financial and Strategic SWOT Analysis Review Summary Par Pharmaceutical Companies, Inc. (Par Pharmaceutical) is a publicly traded pharmaceutical company....

March 2012
FROM

Prescription Drugs - Global Strategic Business Report

This report analyzes the worldwide markets for Prescription Drugs in US$ Billion by the following therapeutic class – Oncologics/ Cancer Drugs, Lipid Regulators, Respiratory Agents, Proton Pump Inhibitors,...

July 2009
FROM

Valeant Pharmaceuticals International - Product Pipeline Review - Q4 2010

Valeant Pharmaceuticals International – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International - Product Pipeline Review -...

December 2010
FROM

Industry Report Card: The Outlook For U.S. For-Profit Health Care Companies Is Stable, As They Face Challenging Industry Changes In 2013 May 13

Abstract Standard & Poor's Ratings Services expects its ratings on the U.S. for-profit health care companies it rates to remain broadly stable in 2013, with a modest negative bias, primarily in the...

May 2013

Valeant Pharmaceuticals International, Inc. - Product Pipeline Review - 2012

Valeant Pharmaceuticals International, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Valeant Pharmaceuticals International, Inc. - Product Pipeline...

May 2012
FROM

North American Corporate Rating Scores By Industry Sector As Of March 5, 2015 May 15

Abstract Standard & Poor's Ratings Services is updating the rating component scores for its public corporate credit ratings in North America. This article follows a similar report published on Feb....

May 2015

Global Corporate Debt Demand Declines To $57 Trillion As Credit Risk Concentrates In China, U.S. Jul 15

Abstract MELBOURNE (Standard & Poor's) July 16, 2015--Global corporate debt demand will peak at an estimated $57 trillion by 2019, a decline of 4% from last year's projection, according to an annual...

July 2015

Soft Drinks - Global Strategic Business Report

This report analyzes the worldwide markets for Soft Drinks in Millions of Liters and US$ Million The major product segments analyzed are Carbonates, and Non-Carbonates The sub product segments analyzed...

February 2006
FROM

Aquaporins, Vol 51. Current Topics in Membranes

Aquaporins summarizes the present knowledge in this expanding field of research, starting with the structural analysis of water channel proteins. Subsequent chapters begin with mammalian aquaporins,...

April 2001
FROM
Loading Indicator

Our Clients

Innocent Drinks Ltd. Groupe Danone Cisco Systems, Inc. The World Bank Group Swarovski AG Owens Corning Corporation Swiss Reinsurance Company Ltd.